Search Results - "Miyagawa, Jun‐Ichiro"
-
1
Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay
Published in Journal of diabetes investigation (01-05-2016)“…Aims/introduction The aims of the present study were to investigate the performance of a novel sandwich enzyme‐linked immunosorbent assay (ELISA) for measuring…”
Get full text
Journal Article -
2
Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules
Published in Frontiers in endocrinology (Lausanne) (20-09-2022)“…Background and objective Pancreatic fat is a form of ectopic fat. Lipid droplets (LDs) are also observed in β cells; however, the pathophysiological…”
Get full text
Journal Article -
3
Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus
Published in Endocrine Journal (2013)“…The effect of add-on therapy with sitagliptin on glycemic control was prospectively investigated in patients with type 2 diabetes mellitus (T2DM) receiving…”
Get full text
Journal Article -
4
The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells
Published in Journal of cellular physiology (01-07-2008)“…CD9 is a member of the tetraspanins, and has been shown to be involved in a variety of cellular activities such as migration, proliferation, and adhesion. In…”
Get full text
Journal Article -
5
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Published in Biochemical and biophysical research communications (02-04-1999)“…We isolated the human adipose-specific and most abundant gene transcript, apM1 (Maeda, K., et al.,Biochem. Biophys. Res. Commun.221, 286–289, 1996). The apM1…”
Get full text
Journal Article -
6
Significance of the regulation of hyperglucagonemia in type 2 diabetes mellitus
Published in Nihon rinshō (01-12-2015)“…Abstract Generally, pancreatic β-cell dysfunction and hypoinsulinemia have been known as the cause of development of hyperglycemia in diabetes mellitus…”
Get more information
Journal Article -
7
Effects of the naturally-occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non-obese subjects
Published in Journal of diabetes investigation (01-05-2013)“…Aims/Introduction Incretins might play some pathophysiological role in glucose metabolism in diabetes and obesity; it is not clear whether or not the amount…”
Get full text
Journal Article -
8
The HNF-1 target Collectrin controls insulin exocytosis by SNARE complex formation
Published in Cell metabolism (01-12-2005)“…Defective glucose-stimulated insulin secretion is the main cause of hyperglycemia in type 2 diabetes mellitus. Mutations in HNF-1α cause a monogenic form of…”
Get full text
Journal Article -
9
Evaluation of a minimally invasive system for measuring glucose area under the curve during oral glucose tolerance tests: usefulness of sweat monitoring for precise measurement
Published in Journal of diabetes science and technology (01-05-2013)“…We developed a system for measuring glucose area under the curve (AUC) using minimally invasive interstitial fluid extraction technology (MIET). Sweat…”
Get full text
Journal Article -
10
Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing
Published in The Journal of cell biology (16-10-2000)“…Keratinocyte proliferation and migration are essential to cutaneous wound healing and are, in part, mediated in an autocrine fashion by epidermal growth factor…”
Get full text
Journal Article -
11
Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin
Published in Endocrine Journal (2013)“…Acarbose was administered at 300 mg/day to patients with type 2 diabetes mellitus (T2DM) who had been taking 25 mg/day of alogliptin, and levels of blood…”
Get full text
Journal Article -
12
Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes
Published in Endocrine Journal (2014)“…The effects of exenatide on glycemic control, lipid metabolism, blood pressure, and gastrointestinal symptoms were investigated in obese Japanese patients with…”
Get full text
Journal Article -
13
Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins
Published in The Journal of clinical investigation (15-05-2002)“…Adiponectin, an adipocyte-derived hormone, was recently shown to have potential therapeutic applications in diabetes and obesity because of its influence on…”
Get full text
Journal Article -
14
New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
Published in Clinical and experimental nephrology (01-02-2013)“…Incretin-based therapy was first made available for the treatment of type 2 diabetes mellitus (T2DM) in the US in 2006 and in Japan in 2009. Four DPP-4…”
Get full text
Journal Article -
15
The -1535 Promoter Variant of The Visfatin Gene Is Associated with Serum Triglyceride and HDL-cholesterol Levels in Japanese Subjects
Published in Endocrine Journal (2008)“…Visfatin is a novel adipocytokine that is expressed by the visceral fat cells. We investigated the role of genetic variation in the visfatin gene in the…”
Get full text
Journal Article -
16
Overexpression of Dominant-Negative Mutant Hepatocyte Nuclear Factor-1α in Pancreatic β-Cells Causes Abnormal Islet Architecture With Decreased Expression of E-Cadherin, Reduced β-cell Proliferation, and Diabetes
Published in Diabetes (New York, N.Y.) (01-01-2002)“…Overexpression of Dominant-Negative Mutant Hepatocyte Nuclear Factor-1α in Pancreatic β-Cells Causes Abnormal Islet Architecture With Decreased Expression of…”
Get full text
Journal Article -
17
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
Published in Endocrine Journal (2011)“…To determine whether miglitol administration improves glycemic control and reduces the frequency of hypoglycemia in type 1 diabetes mellitus (T1DM) patients…”
Get full text
Journal Article -
18
Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents
Published in Nihon rinshō (01-05-2012)Get more information
Journal Article -
19
DPP-4 inhibitor (incretin enhancer)
Published in Nihon rinshō (01-05-2012)Get more information
Journal Article -
20
Incretin-based therapy in patients with type 1 diabetes mellitus
Published in Nihon rinshō (01-05-2011)“…GLP-1 has multiple physiological functions including glucose-dependent insulin secretion and glucagon suppression, delay of gastic emptying, suppression of…”
Get more information
Journal Article